140 related articles for article (PubMed ID: 32604198)
1. Occult Uterine Malignancy at the Time of Surgery for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
Davenport E; James L; Parks T; Howard DL
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e282-e289. PubMed ID: 32604198
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Occult Uterine Pathology in Women Undergoing Hysterectomy With Pelvic Organ Prolapse Repair.
Ackenbom MF; Giugale LE; Wang Y; Shepherd JP
Female Pelvic Med Reconstr Surg; 2016; 22(5):332-5. PubMed ID: 27171317
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Occult Malignancy Within Morcellated Specimens Removed During Laparoscopic Sacrocolpopexy.
Vallabh-Patel V; Saiz C; Salamon C; Francis A; Pagnillo J; Culligan P
Female Pelvic Med Reconstr Surg; 2016; 22(4):190-3. PubMed ID: 26945272
[TBL] [Abstract][Full Text] [Related]
4. The incidence and risk factors of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse.
Ryu SM; Cho JS; Kong MK; Bai SW
Int Urogynecol J; 2023 Nov; 34(11):2719-2724. PubMed ID: 37401960
[TBL] [Abstract][Full Text] [Related]
5. Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction.
Ramm O; Gleason JL; Segal S; Antosh DD; Kenton KS
Int Urogynecol J; 2012 Jul; 23(7):913-7. PubMed ID: 22398824
[TBL] [Abstract][Full Text] [Related]
6. Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse.
Hill AJ; Carroll AW; Matthews CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):113-5. PubMed ID: 24566217
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis.
Nicholson RC; Khunda A; Ballard P; Rees J; McCormick C
Int Urogynecol J; 2021 Dec; 32(12):3131-3141. PubMed ID: 34115164
[TBL] [Abstract][Full Text] [Related]
9. The incidence of occult malignancy following uterine morcellation: A ten-year single institution experience retrospective cohort study.
Mori KM; Abaid LN; Mendivil AA; Brown JV; Beck TL; Micha JP; Epstein HD; Goldstein BH
Int J Surg; 2018 May; 53():239-242. PubMed ID: 29621658
[TBL] [Abstract][Full Text] [Related]
10. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
12. Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA.
Chang OH; Ferrando CA
J Minim Invasive Gynecol; 2021 Apr; 28(4):788-793. PubMed ID: 32681994
[TBL] [Abstract][Full Text] [Related]
13. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
14. Occult uterine malignancy during laparoscopic supracervical hysterectomy.
Gawron I; Skotniczny K; Ludwin A
Ginekol Pol; 2018; 89(9):467-474. PubMed ID: 30318572
[TBL] [Abstract][Full Text] [Related]
15. Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.
Hemming C; Constable L; Goulao B; Kilonzo M; Boyers D; Elders A; Cooper K; Smith A; Freeman R; Breeman S; McDonald A; Hagen S; Montgomery I; Norrie J; Glazener C
Health Technol Assess; 2020 Mar; 24(13):1-220. PubMed ID: 32138809
[TBL] [Abstract][Full Text] [Related]
16. Uterus conserving prolapse surgery--what is the chance of missing a malignancy?
Renganathan A; Edwards R; Duckett JR
Int Urogynecol J; 2010 Jul; 21(7):819-21. PubMed ID: 20135302
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
18. Safety of Manual Morcellation After Vaginal or Laparoscopic-assisted Vaginal Hysterectomy.
Balgobin S; Maldonado PA; Chin K; Schaffer JI; Hamid CA
J Minim Invasive Gynecol; 2016; 23(4):542-7. PubMed ID: 26802908
[TBL] [Abstract][Full Text] [Related]
19. Should we perform subtotal hysterectomy associated with sacral colpopexy for genital prolapse to prevent the risk of endometrial cancer?
Gauthier T; Lacorre A; Legendre G; Golfier F; Touboul C; Deffieux X; Sallee C
Prog Urol; 2021 Jun; 31(7):439-443. PubMed ID: 33867213
[TBL] [Abstract][Full Text] [Related]
20. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.
Baessler K; Christmann-Schmid C; Maher C; Haya N; Crawford TJ; Brown J
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013108. PubMed ID: 30121956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
